Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally
"Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin."
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin, hydroxycholoriquine, Budesonide, Proxalutamide, and many other drugs.
Hell even nicotine has massive prophylaxis benefits.
"Daily active smokers are infrequent among outpatients or hospitalized patients with COVID-19. Several arguments suggest that nicotine is responsible for this protective effect via the nicotinic acetylcholine receptor (nAChR)."
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally
"Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin."
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin, hydroxycholoriquine, Budesonide, Proxalutamide, and many other drugs.
Hell even nicotine has massive prophylaxis benefits.
https://clinicaltrials.gov/ct2/show/NCT04583410
"Daily active smokers are infrequent among outpatients or hospitalized patients with COVID-19. Several arguments suggest that nicotine is responsible for this protective effect via the nicotinic acetylcholine receptor (nAChR)."